Jiangsu Hengrui Medicine
600276.SS
#572
Rank
ยฃ33.84 B
Marketcap
ยฃ5.10
Share price
0.52%
Change (1 day)
-32.15%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Financial Statements

Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2025

Financial Statement 2025

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2024

Financial Statement 2024

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2023

Financial Statement 2023

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2022

Financial Statement 2022

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2021

Financial Statement 2021

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2020

Financial Statement 2020

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2019

Financial Statement 2019

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2017

Financial Statement 2017

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2015

Financial Statement 2015

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2014

Financial Statement 2014

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2013

Financial Statement 2013

Language: Chinese

View Financial Statement
Thumbnail Jiangsu Hengrui Medicine
 Financial Statement 2012

Financial Statement 2012

Language: Chinese

View Financial Statement